» Articles » PMID: 27551428

Neisseria Meningitidis and Streptococcus Pneumoniae As Leading Causes of Pediatric Bacterial Meningitis in Nine Mexican Hospitals Following 3 Years of Active Surveillance

Abstract

Objectives: Meningococcal meningitis is reported as a rare condition in Mexico. There are no internationally published studies on bacterial causes of meningitis in the country based on active surveillance. This study focuses on finding the etiology of bacterial meningitis in children from nine Mexican Hospitals.

Methods: From January 2010 to February 2013, we conducted a three years of active surveillance for meningitis in nine hospitals throughout Mexico. Active surveillance started at the emergency department for every suspected case, and microbiological studies confirmed/ruled out all potentially bacterial pathogens. We diagnosed based on routine cultures from blood and cerebrospinal fluid (not polymerase chain reaction or other molecular diagnostic tests), and both pneumococcal serotyping and meningococcal serogrouping by using standard methods.

Results: Neisseria meningitidis was the leading cause, although 75% of cases occurred in the northwest of the country in Tijuana on the US border. Serogroup C was predominant. Streptococcus pneumoniae followed Neisseria meningitides, but was uniformly distributed throughout the country. Serotype 19A was the most incident but before universal implementation of the 13-valent pneumococcal conjugate vaccine. Other bacteria were much less common, including Enterobacteriaceae and Streptococcus agalactiae (these two affecting mostly young infants).

Conclusions: Meningococcal meningitis is endemic in Tijuana, Mexico, and vaccination should be seriously considered in that region. Continuous universal vaccination with the 13-valent pneumococcal conjugate vaccine should be nationally performed, and polymerase chain reaction should be included for bacterial detection in all cultures - negative but presumably bacterial meningitis cases.

Citing Articles

Serogroup B Meningococcal Sepsis and Meningitis Associated With Meningococcal Acute Otitis Media, and Paranasal Sinusitis in an Infant: A Case Report.

Chacon-Cruz E, Lopatynsky E Cureus. 2023; 15(5):e38430.

PMID: 37273326 PMC: 10234028. DOI: 10.7759/cureus.38430.


Association between Meningococcal Meningitis and Santa Ana Winds in Children and Adolescents from Tijuana, Mexico: A Need for Vaccination.

Chacon-Cruz E, Lopatynsky-Reyes E Trop Med Infect Dis. 2023; 8(3).

PMID: 36977137 PMC: 10055931. DOI: 10.3390/tropicalmed8030136.


Characteristics and risk factors of bacterial meningitis caused by or in Guangzhou China from 2015 to 2022.

Chen D, Tang B, Li Y, Zheng K, Li X, Chen W Front Cell Infect Microbiol. 2023; 12:1092468.

PMID: 36699723 PMC: 9869027. DOI: 10.3389/fcimb.2022.1092468.


Continuous Effectiveness of Pneumococcal 13-Valent Conjugate Vaccine on Pediatric Pneumococcal Otomastoiditis: Results of 15 Years of Active/Prospective Surveillance in a Mexican Hospital on the Mexico-US Border.

Chacon-Cruz E, Lopatynsky E Cureus. 2021; 13(8):e17608.

PMID: 34646659 PMC: 8483408. DOI: 10.7759/cureus.17608.


12 years active surveillance for pediatric pleural empyema in a Mexican hospital: effectiveness of pneumococcal 13-valent conjugate vaccine, and early emergence of methicillin-resistant .

Chacon-Cruz E, Rivas-Landeros R, Volker-Soberanes M, Lopatynsky-Reyes E, Becka C, Alvelais-Palacios J Ther Adv Infect Dis. 2019; 6:2049936119839312.

PMID: 30984396 PMC: 6448099. DOI: 10.1177/2049936119839312.


References
1.
. Meningococcal vaccines: WHO position paper, November 2011. Wkly Epidemiol Rec. 2011; 86(47):521-39. View

2.
Baccarini C, Ternouth A, Wieffer H, Vyse A . The changing epidemiology of meningococcal disease in North America 1945-2010. Hum Vaccin Immunother. 2012; 9(1):162-71. PMC: 3667932. DOI: 10.4161/hv.22302. View

3.
Salgado M, Goncalves M, Fukasawa L, Takenori Higa F, Paulino J, Sacchi C . Evolution of bacterial meningitis diagnosis in São Paulo State-Brazil and future challenges. Arq Neuropsiquiatr. 2013; 71(9B):672-6. DOI: 10.1590/0004-282X20130148. View

4.
Chacon-Cruz E, Sugerman D, Ginsberg M, Hopkins J, Hurtado-Montalvo J, Lopez-Viera J . Surveillance for invasive meningococcal disease in children, US-Mexico border, 2005-2008. Emerg Infect Dis. 2011; 17(3):543-6. PMC: 3166016. DOI: 10.3201/eid1703.101254. View

5.
Safadi M, Cintra O . Epidemiology of meningococcal disease in Latin America: current situation and opportunities for prevention. Neurol Res. 2010; 32(3):263-71. DOI: 10.1179/016164110X12644252260754. View